Product How it works Pricing Blog FAQ About Contact
Utah Medical Products

Utah Medical Products (NASDAQ: UTMD) revenue

Utah Medical Products reported revenue of $38.5m for fiscal 2025, 5.8% less than in fiscal 2024 ($40.9m). Since fiscal 2016 its revenue has fallen by 2.0%, an average decline of 0.2% a year.

Utah Medical Products's revenue has fallen for 3 years in a row, and its best year of the last 10 was fiscal 2022. The biggest drop was in fiscal 2024, −18.6%.

Revenue, in millions of US dollars39.3201641.4201742.0201846.9201942.2202049.1202152.3202250.2202340.9202438.52025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$38.5m−5.8%$11.4m29.6%
2024$40.9m−18.6%$13.6m33.2%
2023$50.2m−3.9%$16.8m33.4%
2022$52.3m+6.6%$19.8m37.9%
2021$49.1m+16.3%$18.9m38.5%
2020$42.2m−10.1%$13.7m32.5%
2019$46.9m+11.7%$17.6m37.6%
2018$42.0m+1.4%$18.7m44.5%
2017$41.4m+5.4%$19.0m45.9%
2016$39.3m—$16.2m41.2%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Utah Medical Products revenue compared with its sector

By revenue for its latest fiscal year, Utah Medical Products ranks 341st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Utah Medical Products, −5.8%.

RankCompanyRevenueRevenue growth
339thVoyager Therapeutics$40.4m−49.5%
340thKymera Therapeutics$39.2m−16.7%
341stUtah Medical Products$38.5m−5.8%
342ndClearPoint Neuro$37.0m17.8%
343rdC4 Therapeutics$35.9m1.0%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Utah Medical Products

How much revenue did Utah Medical Products make in fiscal 2025?
Utah Medical Products reported revenue of $38.5m for fiscal 2025, compared with $40.9m in fiscal 2024.
How much has the revenue of Utah Medical Products fallen?
Between fiscal 2016 and fiscal 2025 it went from $39.3m to $38.5m: 2.0% less, an average decline of 0.2% a year.
What was the best year for revenue at Utah Medical Products?
Of its last 10 fiscal years, fiscal 2022, with $52.3m.
Where does Utah Medical Products rank in its sector by revenue?
It ranks 341st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Utah Medical Products come from?
From the annual report (Form 10-K) that Utah Medical Products files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Utah Medical Products files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Utah Medical Products: the Utah Medical Products page · annual accounts · net income · dividends paid · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.